Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Perrigo

Perrigo Earns IBD Rating Upgrade

A Relative Strength Rating upgrade for Perrigo shows improving technical performance. Will it continue?

Investors Business Daily

Perrigo Trying To Close In On Key Technical Benchmark

Perrigo shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Stocks With Rising Relative Strength: Perrigo

A Relative Strength Rating upgrade for Perrigo shows improving technical performance. Will it continue?

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Dividend Stocks to Buy Now With Yields of About 4% or More

Three dividend stocks, Kimco Realty, Perrigo Company, and Permian Resources, are highlighted as attractive options for investors seeking steady income, with yields of 3.9% or more and strong fundamentals across the real estate, healthcare, and energy sectors.

Barchart

Sensors can read your sweat and predict overheating. Here's why privacy advocates care

As global temperatures rise and summer months bring record high temperatures, employers are exploring wearable technologies to keep workers safe

The Independent UK

Contraceptive brand banishes shame with empowering new packaging

Elmwood builds “a beacon for protection”.

Creative Bloq

First over-the-counter birth control pill heads to stores

Women will be able to buy the pill without a prescription later this month at pharmacies and grocery stores.

WEKU

Read news from The Economist, FT, and more,
with one subscription

3 Pharma Stocks to Consider for March Gains

The pharmaceutical industry is experiencing rapid growth due to rising healthcare spending, an aging population, several technological advancements, and a favorable regulatory environment. Thus, it could be ideal to invest in quality pharma stocks Perrigo (PRGO), OptiNose (OPTN), and Teva Pharmaceutical (TEVA) for solid gains. Keep reading….

StockNews.com

Could Another Baby Formula Shortage Be on the Horizon?

Removing high tariffs from foreign imports of baby formula would ease the supply shock of possible factory closures.

Reason

Will OTC birth control be affordable?

Opill (norgestrel) will be on store shelves in early 2024, but its price could be an issue

Salon

The pill without a prescription: FDA OKs first nonprescription daily oral contraceptive

No prescription will be needed starting early next year when women in the United States will be able to buy the first over-the-counter birth control pill.

Chicago Sun-Times

1st over-the-counter birth control pill approved by FDA

The U.S. Food and Drug Administration approved the nation's first over-the-counter birth control pill after recently being advised to do so by a panel of experts.

LiveScience

First over-the-counter birth control pill approved by US regulators

Perrigo Co.’s Opill received U.S. clearance as the first daily oral birth-control product available without a prescription, coming at a time when reproductive rights are increasingly under fire.

Tribune News Service

The FDA Just Approved OTC Hormonal Birth Control — Here’s When It Will Be Available

Opill becomes the first hormonal birth control pill in the United States to be approved for over-the-counter sale by the Food and Drug Administration.

Inverse

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

FDA approves Opill, the first daily birth control pill without a prescription

From convenience stores to online, the tablet "will be an available option for millions of people in the United States," the director of the FDA's Center for Drug Evaluation and Research says.

Tribune News Service

Perrigo wins US approval for over-the-counter birth control pill

U.S. regulators approved Perrigo Co.’s Opill for over-the-counter use, making it the first daily oral birth-control product to be available without a prescription in the U.S.

Axios

FDA approves 1st over-the-counter daily birth control pill

The decision will likely expand availability of daily birth control pills, but questions around affordability still remain.

The Independent UK

First over-the-counter birth control pill gets FDA approval

U.S. officials have approved the first over-the-counter birth control pill, a major change that will broaden access for women and teenagers

Get all your
news in one place.

100’s of premium titles.
One news app.

Roll Call

FDA approves first OTC birth control pill - Roll Call

The Food and Drug Administration on Thursday approved Opill, making it the nation’s first over-the-counter birth control pill.

Inverse

The FDA Just Approved a Game-Changing OTC Birth Control Pill — Should You Switch to It?

The Opill contains a low dose of progestin at 0.075 milligrams per pill, and has to be taken at the same time every day.

The Independent UK

Recalled Gerber baby formula was sent to US retailers after recall began, wholesaler says

A Gerber infant formula was recalled earlier this year over potential contamination of Cronobacter sakazakii, a bacteria that could cause life-threatening infections in infants

Daily Mirror

Birth control pills should be sold without prescription in US, health advisers say

The panel of Federal Health Advisers (FDA) voted unanimously in favour of drugmaker Perrigo’s request to sell its once-a-day medication over the counter

WEKU

Advisers to the FDA back first over-the-counter birth control pill

In a unanimous vote, 17-0, a panel of advisers to the Food and Drug Administration recommended that the agency approve the first over-the-counter birth control pill.

The Independent UK

FDA panel backs over-the-counter birth control pill

Federal health advisers are recommending that a decades-old birth control pill be sold without a prescription

WEKU

The FDA considers first birth control pill without a prescription

The Food and Drug Administration is weighing whether to allow a birth control pill to be sold over the counter for the first time. An advisory committee opens a two-day hearing Tuesday.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

675 stories

CVS

509 stories

Food and Drug Administration

330 stories

the Food and Drug Administration

177 stories

Medical Pharmaceuticals

Teva Pharmaceutical Industries Limited

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.